Stay updated with breaking news from Franco Valle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) have been assigned an average rating of “Buy” from the six ratings firms that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation and five have issued a buy recommendation on the company. The average 12-month […]
Shares of Biomea Fusion, Inc. (NASDAQ:BMEA – Get Rating) have received an average recommendation of “Buy” from the six ratings firms that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and five have given a buy recommendation to the company. The average twelve-month price objective […]
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
BIOMEA Fusion Strengthens its Executive Team with Appointment of Franco Valle as Chief Financial Officer June 28, 2021 19:10 ET | Source: Biomea Fusion, Inc. Biomea Fusion, Inc. Redwood City, California, UNITED STATES REDWOOD CITY, Calif., June 28, 2021 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea”) (Nasdaq: BMEA), a preclinical-stage biopharmaceutical company focused on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers, announced the appointment of Franco Valle as Chief Financ...
REDWOOD CITY, Calif., June 28, 2021 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (“Biomea”) (NASDAQ:BMEA), a preclinical-stage biopharmaceutical company focused on the discovery and development of irreversible small molecules to treat patients with genetically defined cancers, announced the appointment of Franco Valle as Chief Financial Officer. Mr. Valle is an accomplished financial expert who brings extensive experiences to Biomea, in particular with building the necessary infrastructure to support clinical and operational growth within biotech companies. Mr. Valle will also assume the role...